Verity Pharmaceuticals presents news that is not only specific to our corporation but also includes important information that is relevant to the therapeutic areas represented by our products.


Press Releases

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals - February 2, 2024

FDA-approved antibiotic with life-saving potential launches in Puerto Rico – March 14, 2022

Verity Pharmaceuticals™ and Helsinn Therapeutics sign exclusive agreement for the promotion of Akynzeo® and Valchlor® in Puerto Rico – February 16, 2022

Verity Pharmaceuticals and Acerus Pharmaceuticals form commercial agreement for the promotion of Natesto® in Puerto Rico – January 10, 2022

Debiopharm partners with Verity Pharmaceuticals for the exclusive U.S. commercialization of Trelstar® for prostate cancer – June 9, 2020